WEED is # one so they could buy some of these out. WHO? This list offers investors a growing list of all cannabis-related companies listed on the CSE.
Abattis Bioceuticals (CSE:ATT)
Abattis Bioceuticals is a vertically integrated biotechnology company focused on natural health products, including cannabis. The company develops natural health products and conducts research and development for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets.
This year the Canadian cannabis stock has expanded their work in novel cannabis products with a partnership to develop a hemp-infused, cannabinoid-rich, THC-free craft beer alongside Vancouver-based craft brewery Faculty Brewing.
Alliance Growers (CSE:ACG)
In its attempt to scale up on the cannabis market from a regional, national and international scope, ACG has moved to develop a Cannabis Botany Centre with Botanical Research In Motion International to jointly develop and operate multiple cannabis-focused Botany centers in Canada.
The Canadian cannabis stock provided an update to shareholders on their acquisition of Biocannatech, a late-stage licensed producer applicant under Health Canada’s access to cannabis for medical purposes regulations (ACMPR) in Quebec.
Beleave (CSE:BE)
Next on our stock list for cannabis investment is Beleave, a biotech company with a focus on becoming a licensed producer of medical-grade cannabis under the ACMPR. Its wholly-owned subsidiary, First Access, applied for a pre-license inspection in March 2017.
On January 31 the company announced it received a notification from Health Canada about its pre-sale inspection, which is now scheduled for February 8. If approved the Canadian cannabis stock will obtain a cannabis sales license.
Cannabix Technologies (CSE:BLO)
On the technology side of things, Cannabix Technologies is developing a breathalyzer that detects THC for use by law enforcement. The company announced its inclusion in the CSE25 Index in November 2017.
Most recently the company provided an update to shareholders of the development for their marijuana breathalyzer. “With completion of the modular Beta 3.0 prototype, Cannabix has achieved several key developmental milestones allowing this technology to be directly tested against the accepted laboratory standard of mass spectrometry,” Chief Scientific Officer, Dr. Raj Attariwala said.
Canntab Therapeutics (CSE:PILL)
Canntab is offering investors a different type of play into the cannabis market. The company develops cannabis oral dosage formulations thanks to exclusive technology working in the medical cannabis space.
This company officially launched its public stock on the CSE on April 20. “Canntab was able to take this step on only the second anniversary from its date of incorporation, and we intend to continue taking steps like these to enhance shareholder value, increase liquidity and execute on our strategic vision,” Jeff Renwick, CEO and a director of Canntab said.
CannaRoyalty (CSE:CRZ)
CannaRoyalty puts together its platform of holdings through royalty agreements, equity interests, convertible debt and licensing agreements across Canada and the US. The Canadian cannabis stock seeks to make investments in cannabis companies for the US market, with a direct focus on California, Nevada, and Florida.
After US Attorney General Jeff Sessions rescinded the Cole Memo, the company issued a statement reassuring shareholders of its position in the American market.
“The evidence from legal states demonstrates that legalizing and regulating cannabis consumption works,” Marc Lusting, CEO of CannaRoyalty said. “It is our belief that this Memorandum has more to do with the DOJ’s desire to ensure its ability to continue to enforce federal law without specific enforcement priorities regarding cannabis, than it does to disrupting ongoing state-legal cannabis activity.”
CROP Infrastructure (CSE:CROP)
CROP works with cannabis companies to offer capital for the acquisition of land real estate, branding and infrastructure for operations in the cannabis investment space.
This year the company has obtained 30 percent interest in facilities located in California and Washington State. “CROP continues to aggressively pursue new opportunities to expand its portfolio of tenant growers and infrastructure assets in strategic licensed jurisdictions,” CROP director Alex Horsley said.
Friday Night Inc. (CSE:TGIF)
Friday Night is a cannabis producer based in the state of Nevada, one of the states to most recently legalized the recreational use of cannabis.
The company raised $7.5 million in order to fully capitalize on the high demand of the market in Las Vegas. On June 15, the company began trading on the CSE. Thanks to the boom of the Nevada market, the company is hoping to capitalize on the millions of tourists visiting Las Vegas.
The Canadian cannabis stock announced its intentions to expand its presence into one of the biggest cannabis market available, California.
FinCanna Capital (CSE:CALI)
Next on our stock list for cannabis investment is FinCanna, a royalty company for the licensed medical cannabis industry, with a focus on the California market. The company started trading on December 29, 2017.
Their lead investment is for Cultivation Technologies, which is planning the development of a production facility in Coachella, California. The company announced a C$3 million private placement deal for 16,666,667 units of the company at a C$0.30 price per share. The funds from the transaction will support FinCanna’s royalty investment opportunities.
FSD Pharma (CSE:HUGE)
FSD is a Canadian cannabis company working on the development of an indoor hydroponic cultivation and processing facility, managed by its LP subsidiary FV Pharma. The company started trading on the CSE on May 29.
The facility the company is employing for its growth is a former KRAFT food manufacturing space in Cobourg, Ontario with a 620,000 square feet indoor facility. FSD counts with the support of Auxly Cannabis through a joint-venture agreement. Based on the conditions of the deal Auxly will receive 49.9 percent of the cannabis produced in the facility. “It is anticipated that at full capacity this will result in FV receiving approximately 200,000,000 grams of dried cannabis flower per annum,” FSD wrote in a statement.
Future Farm Technologies (CSE:FFT)
The company works on the development of agriculture technologies for the growth of plants. With the boom of the cannabis industry, Future Farm has expanded their business into marijuana, now representing one of their top 4 business priorities.
Through its subsidiaries, the Canadian cannabis stock has interests in farming projects in Californiarelated to the extraction of THC and CBD strains.
Global Cannabis Application (CSE:APP)
Global Cannabis runs a mobile application business related to the cannabis industry. Their products include Citizen Green, Foro, Opinit and Truth.
The Canadian cannabis stock plans to roll out the launch of their cannabis lifestyle apps CannaLife and CannaMed. The company announced it will launch Citizen Green’s CannaMed and CannaLife apps.
Global Hemp Group (CSE:GHG)
Canadian cannabis stock Global Hemp focuses on the acquisition or joint venturing with companies all over the hemp and cannabis sector. The companies in their network include “suppliers of high quality sustainable raw materials and finished products derived from the hemp plant.”
Global Hemp’s latest joint venture is with Marijuana Company of America (OTC:MCOA) in which the two companies will work on the development of their New Brunswick hemp project.
Golden Leaf Holdings (CSE:GLH)
Listed in Canada but located in Oregon, Golden Leaf Holdings is focused on producing high-quality cannabis oils. Currently, the company’s portfolio of brands is to meet the needs of patients, consumer and strategic partners.
The company gained licenses to sell its products in Las Vegas and other areas in the state of Nevada, a market that has expanded in 2017 with incredibly high demand, following the legalization of cannabis.
Green Thumb Industries (CSE:GTII)
GTI operates and oversees the development of its branded retail cannabis dispensaries called RISE. According to a statement the company currently owns seven manufacturing facilities and holds the licenses of 50 retail locations across Nevada, Florida, Massachusetts, Illinois, Ohio and Pennsylvania.
This year the company was awarded five dispensaries licenses in the state of Ohio. The company plans to open its stores in Cleveland, Toledo, Lorain and two in Lakewood.
High Hampton Holdings (CSE:HC)
Next on our stock list for cannabis investment is High Hampton, a cannabis operator focused on the Californian market. Through its subsidiary, CoachellaGro the company is expanding their reach in the state. As the company awaits for a Conditional Use Permit (CUP) for a 10.8-acre CoachellaGro facility located within the Coachella cultivation zone, in January it announced a strategic planning phase.
During the Lift Cannabis Expo in Vancouver this year, CEO David Argudo gave INN an update on the obstacles facing the California cannabis market. On the topic of risk potential for CSE-listed cannabis operators in the US, the company gave an update to shareholders after Canadian Securities Administrators issued a notice asking companies in this space for a risk disclosure update.
“By further clarifying what is expected of an issuer, the CSA offers valuable guidance on disclosure necessities and further reiterates its commitment to follow this disclosure-based approach,” Argudo said in the statement.
HIKU Brands Company (CSE:HIKU)
Hiku is a Canadian cannabis stock whose company is focused on the lifestyle brand aspect of the industry. The company was created by the same team behind the popular Saxx Underwear.
Previously known as DOJA, the company completed a partnership with Tokyo Smoke to morph its public offering into HIKU. DOJA and all it’s LP product are now a subsidiary of the new enterprise.
iAnthus Holdings (CSE:IAN)
This Canadian cannabis stock offers financing options to other cannabis cultivators, processors, and dispensaries in the US. The company has deals with licensed producers in four states: Colorado, Massachusetts, New Mexico and Vermont. By guiding these many companies iAnthus has a solid grasp on the cannabis sector in America.
iAnthus currently has almost 20 million invested in five cannabis operations since the start of 2016. “We look forward to making additional investments in greenfield states as well as acquiring assets that have strong track records of revenue growth and cash flow generation,” Julius Kalcevich, CFO of iAnthus, said in a statement.
The Canadian cannabis stock made a push for the Florida market by buying the assets of GrowHealthy Holdings a local Florida company.
InMed Pharmaceuticals (CSE:IN)
InMed is developing therapies for patients through the research of cannabinoids in combination with drug delivery systems. The company has a dermatology product with clinical trials planned all throughout 2020.
The Canadian cannabis stock recently shared some results from its co-sponsored study with the University of British Columbia. “The InMed-UBC study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye, resulting in enhanced drug uptake via the cornea and lens,” InMed said.
Isodiol International (CSE:ISOL)
Through its own online store, Isodiol offers a variety of cannabidiol (CBD) products like oils, sprays, and patches. The company has developed proprietary ISO 9001 and GMP-certified cannabinoid production and purification methods to formulate high-quality CBD products.
Isodiol is one of the first Canadian companies to express an interest in entering the Mexican market, following medical legalization in the country. Isodiol announced in early July that it had received approval from the Brazilian Health Regulatory Agency for its pharmaceutical grade Cannabidiol product, Isoderm.
Lexaria Bioscience (CSE:LXX)
Lexaria is food biosciences company that has the technology for improved delivery of bioactive compounds. In particular, the Canadian cannabis stock offers a variety of hemp oil products to its consumers and also has some novel food offerings like a black tea infused with hemp oil.
Lexaria has filed patents in the US to protect their lipid-based delivery mechanisms. On October 31, the company announced it received a US patent for the use of its “technology as a delivery platform for all cannabinoids including THC; fat-soluble vitamins; non-steroidal anti-inflammatory pain medications; and nicotine.”
Lineage Grow Company (CSE:BUDD)
Lineage is a company focused on holding a lineup of licensed producer assets across the US and Canada. The company currently is seeking assets in Oregon, California, Maryland and Pennsylvania.
In June the company announced an agreement to acquire Agris Farms, a premium quality craft cannabis cultivation company in Northern California.
Koios Beverage (CSE:KBEV)
Koios is a company working on the development of a beverage for brain health purposes. In May thecompany announced the start of official testing into patients using the Koios products by the NeuraPerformance/Neuroptimize BrainCente. These centers will soon start offering the beverages in its locations.
“Not only will this clinical trial further substantiate our product formulation, but the data collected will pave the way to creating better technologies within our portfolio,” Chris Miller, CEO of Koios said.
Lotus Ventures (CSE:J)
Lotus Ventures is a cannabis company with a 22,500-square foot indoor growing facility set to be completed in August 2018 in Armstrong, B.C. The company obtained a confirmation of readiness from Health Canada indicating an acceptance of Lotus’ application.
The company was able to have the facility completely paid out thanks to a recent financing deal worth C$12 million from Auxley Cannabis Group (TSXV:XLY), formerly Cannabis Wheaton, and a closed financing deal in which the company sold over 10 million units.
Liberty Health Sciences (CSE:LHS)
Liberty Health is a company focused on cannabis opportunities in the US. They are partnered with Aphria (TSX:APH; OTCQB:APHQF) Currently, Liberty Health is focused on the market available in Florida, including a variety of deals to provide cannabis products to that state.
Liberty Leaf (CSE:LIB)
Liberty Leaf Holdings is focused on the business of acquiring partnership interests in up-and-coming and established companies in the medicinal and recreational cannabis investment space. On October 27, the Canadian cannabis stock announced it received an aggregate $763,500 from the exercise of share purchase warrants.
Marapharm Ventures (CSE:MDM)
Next on our stock list for cannabis investment is Marapharm Ventures. The company has two operations in British Columbia. The company’s initial facility–a proposed 22,000 square feet area –will be on an 11-acre site in Kelowna.
Marapharm has also purchased land in Las Vegas for the purpose of building a facility that will host three medical marijuana licenses. What’s more, the company also has the opportunity in Washington to lease a facility to a tier 3 license holder.
Maricann (CSE:MARI)
Maricann is a licensed producer of cannabis in Canada with a production facility in Langton, Ontario. As part of its fiscal 2017 results the company reported revenue of just over C$3.2 million accompanied with a net loss per share worth C$0.97.
This year the company confirmed its intentions to export cannabis into Europe after its Site 150 facility obtained a European Medicines Agency Good Manufacturing Practice (EMA-GMP). “We maintain our position that establishing sustainable baskets of margin for our products that will be preserved over the long term is more important than immediate gross revenue,” CEO of the company Ben Ward said in a Q1 2018 report update.
Matica Enterprises (CSE:MMJ)
Matica is involved in the acquisition of 70 percent of a late stage ACMPR applicant and builds a 10,000 square foot facility in Quebec.
This facility received its official inspection by the management team of Matica, with CEO Boris Zieger saying their facility is on schedule and should be done by November of 2017.
MedMen Enterprises (CSE:MMEN)
MedMen is a cannabis dispensary operator focused on the US market. The company owns dispensaries in key states like California and Nevada and has been able to hold onto a popularity to its branding and promotion.
MedMen signed onto a partnership with LP Cronos Group for a joint venture and the creation of MedMen Canada, this new entity will oversee the creation of cannabis dispensaries in Canada modeled similarly to the popular MedMen stores in the US.
MPX Bioceutical Corporation (CSE:BCC)
MPX is a US operator with businesses in legal states like Arizona, Massachussetts and Nevada. This year the company expanded its footprint and revenue from Arizona thanks to the purhcase of a network of assets.
The company has also had its eyes in the Canadian market. MPX has a facility under development in Owen Sound, Ontario and recently purchased a 12,000 square foot fully constructed and licensed facility in Peterborough, Ontario.
MYM Nutraceuticals (CSE:MYM)
MYM has been working on the development of its Weedon facility in Quebec, a planned 1.5 million square foot greenhouse space for cannabis production. The company completed the acquisition of the 329 acres needed for this planned facility in June, 2018.
The plans for the facility include a full tourism suite of options like restaurants, museums, hotels and more.
NanoSphere (CSE:NSHS)
NanoSphere is a biotech company working on novel delivery methods. Their relation to the cannabis industry comes in the form of technology. Most recently the Canadian cannabis stock announced a dealwith a private-label manufacturer of pharmaceutical goods based in California.
“This new venture not only opens up a huge market, but is a fantastic opportunity to increase our visibility and reputation in the legal cannabis investment space, and represents a significant stepping stone to reaching even more new patients and consumers with our lauded transdermal delivery system,” Robert Sutton, Chairman and CEO at NanoSphere said.
Nutritional High (CSE:EAT)
Nutritional High is a Canadian cannabis stock focused on cannabis-infused edible products and oil extracts for both the medical and recreational market. On October 8, the company announced it was entering into a novel cannabis market: beverages. The company “entered into an agreement with Xanthic Biopharma to manufacture and distribute their innovative cannabis-infused powdered drinks and other products in Colorado.
Phivida Holdings (CSE:VIDA)
Next on our stock list for cannabis investment is Phivida. The company works on CBD infused foods and beverages and clinical CBD products. Most recently the company announced an agreement with Namaste Technologies (CSE:N; OTCMKTS:NXTTF) to distribute their products in Germany and Australia.
“This Agreement represents a pilot project between both companies whereby Namaste will distribute Phivida’s proprietary CBD beverages and infused products within the designated territories,” the companies announced on their joint statement.
Planet 13 Holdings Inc. (CSE:PLTH)
Another US focused operator, Planet 13 Holdings has assets in Nevada. The company operates six active licenses with cultivation, production, and dispensary infrastructure.
After its CSE debut in June, 2018 the company announced it’s working on the development of a phase 1 “Planet 13 Superstore” located strategically close to the Las Vegas strip.
PUF Ventures (CSE:PUF)
PUF Ventures has a diversified portfolio of assets in the Canadian marijuana sector. It owns a passive, non-controlling interest in AAA Heidelberg, which is focused on using all-natural nutrients to grow healthy, pest-free plants.
AAA Heidelberg has had an MMPR application pending with Health Canada since 2013. Other ventures the company has invested in include 1313 Cigs, VapeTronix, and Weed Beacon. In late January, the Canadian cannabis stock announced it had recommenced its development of the WeedBacon platform.
Quadron Capital Corporation (CSE:QCC)
Quadron works to help licensed producers in Canada with “complex needs and requirements” through equipment, products, and services. The company also offers dispensing devices and consumption products. The company has two subsidiaries in Soma Labs Scientific, Greenmantle, and Cybernetic Control Systems.
During its most recent financial disclosure, the Canadian cannabis stock announced an increase in revenue to $516,211 during their first quarter.
RISE Life Science (CSE:RLSC)
RISE Life Science is a company developing cannabis consumer products for both medical and adult-use markets. The company plans to establish a potential capacity in 2019 to market all of its CBD products throughout the US, Canadian and European markets.
In June the company provided shareholders with a corporate update to project the entry of sexual health cannabis products this year. “RISE products are expected to be available in California retail locations by the end of July and will be offered through dispensaries initially, followed by health food retailers and natural wellness boutiques,” the company indicated.
TerrAscend (CSE:TER)
Another fairly new member of the Canadian cannabis stocks is TerrAscend, who went public in May 2017 when it entered the Canadian Securities Exchange. The company’s subsidiary, Solace Health, is in the process of applying for an official licensing designation from Health Canada. Solace is host to a 67,000 square feet production facility
The company’s other subsidiary Terra Health Network is a research-based cannabinoid medical group, which wants to improve the medical cannabis solutions available for patients with chronic pain and debilitating illnesses.
THC Biomed (CSE:THC)
Next on our stock list for cannabis investment is THC Biomed, who has been granted permission to conduct research and development for scientific purposes with medicinal marijuana. The company provides scientific and biotechnical services to current and potential licensed producers. In May 2016, Health Canada granted TCH BioMed a license to produce fresh marijuana, cannabis oil, and cannabis resin.
Tinley Beverage (CSE:TNY)
Tinley Beverage is the producer of Hemplify, a drinkable vitality supplement containing hemp extract made from the stalk of industrial hemp. The vegan, sugar-free drink is a source of electrolytes, vitamins and Omega 3 fatty acids. The company reported receiving its first orders for Hemplify products on March 10, 2016. In August 2016 the company launched its web store at www.drinkhemplify.com and listed its flagship “Hemplify” product for sale on Amazon.
True Leaf Medicine (CSE:MJ)
Canada-based True Leaf is slightly different than the afore-mentioned Canadian cannabis stocks; the company is focused on the production of hemp-based functional dog chews. In August 2016, the company secured the first order for its True Hemp pet products with Pets Corner, the second largest pet store chain in the United Kingdom. The store will sell the product in all of its 174 stores. The sale also means that True Hemp is now generating revenue on two continents – North America and Europe. “We’re on our way to becoming a truly global brand,” said CEO Darcy Bomford.
Valens GroWorks (CSE:VGW)
Located in British Columbia’s Okanagan Valley, our next Canadian cannabis stocks is Valens GroWorks, a “rapidly emerging” with a focus on cannabis cultivation and research. In November the company announced it had increased a private placement offer in order to advance the operational capability of its Kelowna Facility.
Veritas Pharma (CSE:VRT)
Veritas is working on fully understanding the medical capabilities of marijuana, the company’s mission is to find the most effective strains that target a specific disease condition. Veritas is using a specifically designed approach to their research where they chemically and pharmacologically profile the plant. As a last check, they completed a clinical study of each cultivar.
Vinergy Resources (CSE:VIN)
Vinergy is an oil and gas company, that acquired MJ BioPharma, a cannabis technology company focused on manufacturing breath strips, time release capsules, extract oils, food products, and infused juices, teas, coffee and extract drinks and pharmaceutical grade delivery systems.
The pair announced in February the had developed an oral cannabinoid complex delivery strips and controlled time release capsule technology. “We think time release capsules are extremely important as they help bridge the gap in terms of familiarity with many patients who want to switch from synthetic drugs to a natural product as a way to reduce side effects and drug,” said Mr. Kent Deuters, CEO of MJ Biopharma.
Vodis Pharmaceuticals (CSE:VP)
Next on our stock list for cannabis investment is Vodis. The firm has medical and recreational marijuana business operations in both Canada and the United States. With facilities in BC and Washington State, Vodis is actively seeking expansion opportunities in other countries and US states.
In March, the company announced it, together with Our Church International, signed a 15-year licensing and marketing agreement. Later that month, Vodis announced construction had begun on its Bellingham cannabis facility. Following that, the Canadian cannabis stock announced its USA-branded product had begun selling in Washington State. On June 20, Vodis announced a $5 million private placement financing.
Wildflower Brands (CSE:SUN)
Working exclusively in Washington State, Wildflower Marijuana lists in Canada, with a focus on developing and designing products in the cannabis sector.
On June 27, Wildflower announced that its products would soon be coming to Amazon.com–which shouldn’t come as a surprise. Earlier in June, the company announced a brand expansion into the American market.
Xanthic Biopharma (CSE:XTHC)
Last but not least on our stock list for cannabis investment is Xanthic. It is a company working with strategic partners to deliver a higher quality of cannabinoid solubility, improved bioavailability, accurate micro-dosing and greater consistency versus competitive infused products, thanks to a patent-pending process.
In May a strategic partner of the company, Avitas CBD Water, rebranded into Xanthic Beverages. “With a business model focused on licensing our water-soluble technology and brand name to qualified producers, being able to demonstrate initial success on the West Coast of the US with Xanthic CBD Water will be extremely valuable,” Tim Moore, CEO of Xanthic said.